Abstract:Purpose of ReviewOver the past 2 decades, our understanding of the role of genetics in the development and progression of aortic disease has grown considerably. This review serves as a foundational text for the reader to gain a thorough understanding of the basics of this emerging field while also displaying the latest breakthroughs which have had, and will continue to have, important impacts on clinical decision-making and patient outcomes. This review focuses on aneurysmal disease, arguably the richest subgroup of aortic diseases for genetic research.Recent FindingsThoracic aortic aneurysm and dissection (TAAD) is driven primarily by genetic factors. Genetic variants which drive TAAD tend to occur in genes involved in the structure and function of the aortic wall, specifically the extracellular matrix, TGF-β pathway, and smooth muscle cell contractile units. At least 37 gene variants (pathological or of unknown significance) have been found to be directly associated with the development of TAAD, independent of traditional cardiovascular (CV) risk factors such as smoking and hypertension. The standard suggestion for definitive treatment is prophylactic surgery at an aortic diameter of 5.0–5.5 cm, but several gene variants have been shown to dissect commonly at much smaller diameters (such as TGFβR1/2 or ACTA2), and so mutation-specific guidelines are leading to earlier surgery and better patient outcomes in these aggressive cases.Abdominal aortic aneurysms (AAAs) also have a genetic component, but these are primarily driven by CV risk factors. Many gene variants have been found which are closely associated with these risk factors, such as those in the lipid metabolism pathway (SORT1). Four variants have been found through GWAS studies to directly influence AAAs independent of general risk factors, though the clinical implications are yet unclear.SummaryNew variants are discovered every year, and each creates a new avenue of research. As more data is collected on patients with each variant, such as the rate of growth, mode of inheritance, age at dissection, and diameter at dissection, we can craft more patient-specific guidelines for different subgroups of affected individuals, with the aim of achieving better long-term survival.

Therapeutics Targeting Drivers of Thoracic Aortic Aneurysms and Acute Aortic Dissections: Insights from Predisposing Genes and Mouse Models

Pathophysiology of aortic aneurysm: insights from human genetics and mouse models

Molecular Mechanisms in Genetic Aortopathy-Signaling Pathways and Potential Interventions

Using Genomics to Identify Novel Therapeutic Targets for Aortic Disease

Inflammation in thoracic aortic aneurysms

Animal Models, Pathogenesis, and Potential Treatment of Thoracic Aortic Aneurysm

Genetics and mechanisms of thoracic aortic disease

Novel Insights into the Aortic Mechanical Properties of Mice Modeling Hereditary Aortic Diseases

Unraveling the Role of TGFβ Signaling in Thoracic Aortic Aneurysm and Dissection Using Fbn1 Mutant Mouse Models

TGFBR2 Mutations Alter Smooth Muscle Cell Phenotype and Predispose to Thoracic Aortic Aneurysms and Dissections

The Genetics of Inheritable Aortic Diseases

Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/- mice.

Loss of Transforming Growth Factor Beta Signaling in Aortic Smooth Muscle Cells Causes Endothelial Dysfunction and Aortic Hypercontractility

Genetic insights into therapeutic targets for aortic aneurysms: A Mendelian randomization study

Altered Transforming Growth Factor-Beta Signaling in a Murine Model of Thoracic Aortic Aneurysm

Short-Term Disruption of TGFβ Signaling in Adult Mice Renders the Aorta Vulnerable to Hypertension-Induced Dissection

Comparison of 10 murine models reveals a distinct biomechanical phenotype in thoracic aortic aneurysms

MicroRNAs, fibrotic remodeling, and aortic aneurysms

Abstract 5314: A Critical Role for TGF- Β Activity in the Protection Against Aortic Aneurysm Formation and Complications in Adult Mice

Insights From the Histopathologic Analysis of Acquired and Genetic Thoracic Aortic Aneurysms and Dissections

The activator protein-1 complex governs a vascular degenerative transcriptional programme in smooth muscle cells to trigger aortic dissection and rupture